☰

John Barkinge, PhD - Publications

Affiliations: 
Ben May Department for Cancer Biology and Institute for Genomics and Systems Bio University of Chicago, Chicago, IL 
Area:
Systems analysis of proteins
Tree Info Similar researchers PubMed Report error

9/10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Leung KK, Hause RJ, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Molecular & Cellular Proteomics : McP. 13: 1705-23. PMID 24728074 DOI: 10.1074/Mcp.M113.034876  0.595
2012 Hause RJ, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. Plos One. 7: e44471. PMID 22973453 DOI: 10.1371/Journal.Pone.0044471  0.599
2010 Wojcik J, Hantschel O, Grebien F, Kaupe I, Bennett KL, Barkinge J, Jones RB, Koide A, Superti-Furga G, Koide S. A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain. Nature Structural & Molecular Biology. 17: 519-27. PMID 20357770 DOI: 10.1038/Nsmb.1793  0.654
2009 Gudi R, Barkinge J, Hawkins S, Prabhakar B, Kanteti P. Siva-1 promotes K-48 polyubiquitination of TRAF2 and inhibits TCR-mediated activation of NF-kappaB. Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society For Environmental Toxicology and Cancer. 28: 25-38. PMID 19392652 DOI: 10.1615/Jenvironpatholtoxicoloncol.V28.I1.30  0.334
2009 Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV. The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis. Journal of Carcinogenesis. 8: 2. PMID 19240372 DOI: 10.4103/1477-3163.45389  0.475
2008 Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Molecular Cancer Research : McR. 6: 885-91. PMID 18567793 DOI: 10.1158/1541-7786.Mcr-07-0369  0.632
2006 Gudi R, Barkinge J, Hawkins S, Chu F, Manicassamy S, Sun Z, Duke-Cohan JS, Prasad KV. Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene. 25: 3458-62. PMID 16491128 DOI: 10.1038/Sj.Onc.1209381  0.513
2005 Chu F, Barkinge J, Hawkins S, Gudi R, Salgia R, Kanteti PV. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2. Cancer Research. 65: 5301-9. PMID 15958577 DOI: 10.1158/0008-5472.Can-04-3270  0.353
2004 Chu F, Borthakur A, Sun X, Barkinge J, Gudi R, Hawkins S, Prasad KV. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis : An International Journal On Programmed Cell Death. 9: 83-95. PMID 14739602 DOI: 10.1023/B:Appt.0000012125.01799.4C  0.554
Low-probability matches (unlikely to be authored by this person)
2009 Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KVS. The p53 induced Siva-1 plays a significant role in cisplatin-induced apoptosis Journal of Carcinogenesis. 8. DOI: 10.4103/1477-3163.45389  0.108
Hide low-probability matches.